Drgem
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Drgem makes X-ray imaging machines used by hospitals and clinics to diagnose patients, covering both older analog systems and modern digital systems that produce sharper diagnostic images.
It supplies these systems to medical facilities and distributes them through a network of dealers across roughly one hundred twenty countries worldwide. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company designs and manufactures its own core components, including the generator, tube, collimator, and imaging software, rather than relying entirely on outside suppliers.
Summary is AI-generated and may contain errors · figures from DART filings
The company states that designing and manufacturing key components in-house, including under OBL and OEM arrangements, is a central competitive capability that distinguishes it from rivals.
Drgem in five facts
What does Drgem do?
Drgem makes X-ray imaging machines used by hospitals and clinics to diagnose patients, covering both older analog systems and modern digital systems that produce sharper diagnostic images.
Where is Drgem listed and in which sector?
Drgem (Korean name: 디알젬) trades under KRX code 263690 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Drgem?
Its market capitalisation was US$43.4M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Drgem's latest annual revenue and operating profit?
For fiscal year 2025, Drgem reported revenue of US$77.5M, operating profit of US$6.8M and net income of US$5.1M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 1.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Supply contract signed
Drgem Corporation signed a US$13.1M (USD 12,995,466) contract on July 21, 2026 to supply X-ray medical devices to Turkey, equal to 18.74% of its most recent revenue, with payment due within 160 days of product shipment; the counterparty's identity is withheld at its request.
Supply contract · Jul 22 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Drgem reported consolidated results for FY2025: revenue of US$69.9M (−1.2% year on year), operating profit of US$6.15M (+2.2% year on year) and net income of US$4.59M (−33.5% year on year).
Earnings · Feb 6 - Cash/in-kind dividend decision
Drgem declared a cash dividend of US$0.12 per share.
Dividend · Feb 6